Citius Pharmaceuticals Announces $76.5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules ...Middle East

CRANFORD, N.J., Feb. 17, 2021 /PRNewswire/ -- Citius Pharmaceuticals, Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a specialty pharmaceutical company focused on developing and commercializing critical care drug products, today announced that it has entered into definitive agreements...

Hence then, the article about citius pharmaceuticals announces 76 5 million registered direct offering priced at the market under nasdaq rules was published today ( Wednesday 17/02/2021 - 09:15 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Citius Pharmaceuticals Announces $76.5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules )

Also on site :

• This CEO became 3x more productive with AI. Then she read what her daughter wrote about it at Dartmouth
• Robby Starbuck Calls John Cornyn's 'Keyboard Warrior' BLUFF With EPIC Challenge and We Are Here FOR IT
• Understanding Supplements for Toenail Fungus: PureHealth Research Highlights Oregano, Turmeric, and Olive Leaf